EPIPHANY BUSINESS SERVICES, LLC – Trademark Portfolio
Entity Type: 16
EPIPHANY BUSINESS SERVICES, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EPIPHANY and EPIPHANY DERMATOLOGY. The owner is based in AUSTIN, TX.
6601 VAUGHT RANCH ROAD
STE. 200
AUSTIN, TX 78730
Showing of trademarks Trademarks
Trademark Classifications
EPIPHANY BUSINESS SERVICES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does EPIPHANY BUSINESS SERVICES, LLC have?
EPIPHANY BUSINESS SERVICES, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does EPIPHANY BUSINESS SERVICES, LLC file in?
EPIPHANY BUSINESS SERVICES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 3 (Cosmetics & Cleaning). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are EPIPHANY BUSINESS SERVICES, LLC's most well-known trademarks?
EPIPHANY BUSINESS SERVICES, LLC's registered trademark portfolio includes well-known marks such as EPIPHANY and EPIPHANY DERMATOLOGY. These are among 3 currently registered trademarks in the portfolio.
What is EPIPHANY BUSINESS SERVICES, LLC's trademark registration success rate?
EPIPHANY BUSINESS SERVICES, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.